1 Min Read
Aug 24 (Reuters) - Samsung Bioepis Co Ltd
* Samsung Bioepis Co Ltd announced the European Commission’s approval of Imraldi, a biosimilar referencing Humira Source text for Eikon: [ID: nBw60ydvZa]
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.